Ranbaxy Seeks Mistrial In Nexium Pay-For-Delay Case
Ranbaxy Laboratories Ltd. moved for a mistrial Wednesday in a pay-for-delay case in Massachusetts federal court over the heartburn treatment Nexium, arguing the court's shifting stance on the nature of the...To view the full article, register now.
Already a subscriber? Click here to view full article